Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026986 (
myelodysplastic syndrome
)
14,926
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To gain insight into the poorly understood pathophysiology of the
myelodysplastic syndromes
(MDSs), we have determined the gene expression profiles of the CD34+ cells of 55 patients with
MDS
by using a comprehensive array platform. These profiles showed many similarities to reported interferon-gamma-induced gene expression in normal CD34+ cells; indeed the 2 most up-regulated genes, IFIT1 and
IFITM1
, are interferon-stimulated genes (ISGs). Alterations in the expression of ISGs may play a role in the hematologic features of
MDS
, such as peripheral blood cytopenias. Up-regulation of IFIT1 is a potential diagnostic marker for
MDS
. We determined whether distinct gene expression profiles were associated with specific FAB and cytogenetic groups. CD34+ cells from patients with refractory anemia with ringed sideroblasts (RARS) showed a particular gene expression profile characterized by up-regulation of mitochondrial-related genes and, in particular, of those of heme synthesis (eg, ALAS2). CD34+ cells from patients with the del(5q) had a distinct gene expression profile, characterized by down-regulation of genes assigned to 5q, and up-regulation of the histone HIST1 gene cluster at chromosome 6p21 and of genes related to the actin cytoskeleton. This study provides important and new insights into the pathophysiology of
MDS
.
...
PMID:Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype. 1652 91
Myelodysplastic syndrome
(
MDS
) is a heterogeneous hematologic malignancy derived from hematopoietic stem cells and the molecular mechanism of
MDS
remains unclear. This study aimed to elucidate potential markers of diagnosis and prognosis of
MDS
. The gene expression profiles GSE19429 and GSE58831 were obtained and downloaded from the Gene Expression Omnibus (GEO) database. The differentially expressed genes (DEGs) in
MDS
were screened using GEO2R and overlapped DEGs were obtained with Venn Diagrams. Then, Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway functional enrichment analyses, protein-protein interaction network establishment and survival analyses were performed. Functional enrichment analysis indicated that these DEGs were significantly enriched in the interferon signaling pathway, immune response, hematopoietic cell lineage and the FOXO signaling pathway. Four hub genes and four significant modules including 25 module genes were obtained via Cytoscape MCODE. Survival analysis showed that the overall survival of
MDS
patients having BLNK, IRF4,
IFITM1
, IFIT1, ISG20, IFI44L alterations were worse than that without alterations. In conclusion, the identification of these genes and pathways helps understand the underlying molecular mechanisms of
MDS
and provides candidate targets for the diagnosis and prognosis of
MDS
.
...
PMID:Screening and identification of key candidate genes and pathways in myelodysplastic syndrome by bioinformatic analysis. 3180 41